Oil’s Iran Cliffhanger: What To Know And What To Expect
- Analysis
- Barani Krishnan
- 3
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Xvivo Perfusion AB (XVIVO)
"Xvivo Perfusion AB stock price live, this page displays ST XVIVO stock exchange data. View the XVIVO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Xvivo Perfusion AB real time stock price chart below.
What Is the Xvivo Perfusion AB Stock Price Today?
The Xvivo Perfusion AB stock price today is 444.00.
What Is the Stock Symbol for Xvivo Perfusion AB?
The stock symbol for Xvivo Perfusion AB is ""XVIVO.""
What Stock Exchange Does Xvivo Perfusion AB Trade On?
Xvivo Perfusion AB is listed and trades on the Stockholm stock exchange.
Is Xvivo Perfusion AB a Good Stock to Buy?
Determining whether Xvivo Perfusion AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XVIVO quote. (ISIN: SE0004840718)"
What Is the Xvivo Perfusion AB Stock Price Today?
The Xvivo Perfusion AB stock price today is 444.00.
What Is the Stock Symbol for Xvivo Perfusion AB?
The stock symbol for Xvivo Perfusion AB is ""XVIVO.""
What Stock Exchange Does Xvivo Perfusion AB Trade On?
Xvivo Perfusion AB is listed and trades on the Stockholm stock exchange.
Is Xvivo Perfusion AB a Good Stock to Buy?
Determining whether Xvivo Perfusion AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the XVIVO quote. (ISIN: SE0004840718)"
Stockholm
Currency in SEK
444.00
-3.00(-0.67%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
441.50
450.50
52 wk Range
252.50
547.00
XVIVO Scorecard
Full Analysis
Stock has taken a big hit over the last week
Earnings results expected in 9 days
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
441.50450.50
52 wk Range
252.50547.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
XVIVO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
525.33
Upside
+18.32%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Oil’s Iran Cliffhanger: What To Know And What To Expect
- Analysis
- Barani Krishnan
- 3
Xvivo Perfusion AB Company Profile
Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden, the United States, the Netherlands, Italy, North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment. In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation. The company was incorporated in 1998 and is headquartered in Mölndal, Sweden.
Compare XVIVO to Peers and Sector
Metrics to compare | XVIVO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipXVIVOPeersSector | |
|---|---|---|---|---|
P/E Ratio | 68.5x | −3.5x | −0.6x | |
PEG Ratio | 0.10 | −0.03 | 0.00 | |
Price/Book | 6.7x | 2.3x | 2.6x | |
Price / LTM Sales | 18.6x | 5.3x | 3.1x | |
Upside (Analyst Target) | 19.4% | 49.5% | 53.6% | |
Fair Value Upside | Unlock | 17.5% | 8.0% | Unlock |
Analyst Ratings
2 Buy
3 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 525.33
(+18.32% Upside)
Earnings
Latest Release
Oct 24, 2024
EPS / Forecast
2.76 / 0.8289
Revenue / Forecast
198.00M / 205.77M
People Also Watch
FAQ
What Is the Xvivo Perfusion AB (XVIVO) Stock Price Today?
The Xvivo Perfusion AB stock price today is 444.00
What Stock Exchange Does Xvivo Perfusion AB Trade On?
Xvivo Perfusion AB is listed and trades on the Stockholm stock exchange.
What Is the Stock Symbol for Xvivo Perfusion AB?
The stock symbol for Xvivo Perfusion AB is "XVIVO."
What Is the Xvivo Perfusion AB Market Cap?
As of today, Xvivo Perfusion AB market cap is 13.99B.
What is Xvivo Perfusion AB Earnings Per Share?
The Xvivo Perfusion AB EPS is 6.57.
What Is the Next Xvivo Perfusion AB Earnings Date?
Xvivo Perfusion AB will release its next earnings report on Jan 27, 2025.
From a Technical Analysis Perspective, Is XVIVO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.